Frequency of ischemic symptoms
Suzuki stage, moyamoya disease, cerebral ischemia, neurological abnormalities
DISEASE, MOYAMOYA DISEASE, CEREBRAL ISCHEMIA
As a result of this study, the effect on reducing the frequency of ischemic symptom was not statistically significant. The following factors can be considered for these results of this study.First, although the program of this study was effective in inducing positive changes in the knowledge and health behaviors of adolescents with moyamoya disease, the lack of improvement in the frequency of cerebral ischemia indicates that the measurement index did not sensitively reflect neurological symptoms. That is, only the frequency of ischemic symptom was measured, and it is considered that clinical symptom indicators such as the intensity and duration of neurological abnormalities were not sufficiently reflected. Therefore, in future studies, it is suggested to apply various outcome scales that can be measured by sufficiently reflecting the clinical characteristics of moyamoya disease.Second, both the intervention group and the control group participating in this study corresponded to the relatively stable group when judging the severity of moyamoya disease. That is, not only the study participant but also the participant’s parent fully understood the purpose of this study and agreed to participate. The participantswere in a relatively stable stage who were receiving regular check-ups afterward or who were currently undergoing regular check-ups to check the progression of the disease without a surgical plan. Therefore, in future research, it is suggested to conduct a study design and intervention that considers the severity or stage of moyamoya disease (Suzuki stage) as a block factor [